UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 4, 2004
ATRIX LABORATORIES, INC.
| Delaware | 0-18231 | 84-1043826 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 2579 Midpoint Drive, Fort Collins, Colorado | 80525 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (970) 482-5868
Item 12. Results of Operations and Financial Condition.
On August 4, 2004, Atrix Laboratories, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ATRIX LABORATORIES, INC. |
||||
| By: | /s/ Gregory A. Gould | |||
| Gregory A. Gould | ||||
| Chief Financial Officer, Secretary and Treasurer | ||||
Date: August 4, 2004
3
EXHIBIT INDEX
| Exhibit |
Description |
|
99.1
|
Press Release dated August 4, 2004 |